The focal adhesion protein Integrin-Linked Kinase (ILK) as an important player in breast cancer pathogenesis

Cell Adh Migr. 2020 Dec;14(1):204-213. doi: 10.1080/19336918.2020.1829263.

Abstract

Cell-extracellular matrix interactions, or focal adhesions (FA), are crucial for tissue homeostasis but are also implicated in cancer. Integrin-Linked Kinase (ILK) is an abundantly expressed FA protein involved in multiple signaling pathways. Here, we reviewed the current literature on the role of ILK in breast cancer (BC). Articles included in vitro and in vivo experiments as well as studies in human BC samples. ILK attenuation via silencing or pharmaceutical inhibition, leads to apoptosis or inhibition of epithelial-to-mesenchymal transition, and cell invasion whereas ILK overexpression suppresses anoikis and promotes tumor growth and metastasis. Finally, ILK is upregulated in BC tumors and its expression is associated with grade, and metastasis. Therefore, ILK should be evaluated as a potential anti-cancer pharmaceutical target.

Keywords: Akt; Breast cancer; EMT; ILK; PARVA; PINCH-1; Rictor; focal adhesions; invasion; metastasis.

Publication types

  • Review

MeSH terms

  • Animals
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / pathology*
  • Cell Line, Tumor
  • Epithelial-Mesenchymal Transition
  • Female
  • Focal Adhesions / metabolism*
  • Humans
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology
  • Protein Serine-Threonine Kinases / metabolism*

Substances

  • integrin-linked kinase
  • Protein Serine-Threonine Kinases

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.